Home > Mutual Funds > Gabelli Healthcare & WellnessRx Trust Performance

Objective  Fund Details  Price & Performance  Dividend & Tax Info 

Gabelli Healthcare & WellnessRx Trust

Printable Factsheet  |   Recent Quarterly Report  |   Recent Annual Report  |  

Portfolio Manager: Team Managed Ticker Symbol: GRX

Fund Performance by Month

As of May 22, 2013		  
Year Jan
(%)		 Feb
(%)		 Mar
(%)		 Apr
(%)		 May
(%)		 Jun
(%)		 Jul
(%)		 Aug
(%)		 Sep
(%)		 Oct
(%)		 Nov
(%)		 Dec
(%)		 Year
(%)
2013 + 6.39  + 0.79  + 6.38  + 3.15  + 3.23                +21.47 
2012 + 4.94  + 3.47  + 5.41  + 0.72  - 4.18  + 5.37  + 0.00  + 3.47  + 3.87  - 1.25  + 1.26  + 0.22  +25.37 
2011 - 1.06  + 6.79  + 2.46  + 5.45  + 2.13  - 0.66  - 2.43  - 4.41  - 6.97  + 8.01  + 0.00  + 0.12  + 8.67 
2010 - 0.64  + 2.08  + 3.68  - 0.49  - 5.79  - 2.88  + 1.48  - 4.51  + 7.50  + 2.33  - 0.38  + 7.48  + 9.28 
2009 - 0.81  - 8.12  + 3.00  + 5.15  + 4.08  + 3.29  + 5.92  + 1.86  + 4.22  - 1.89  + 2.75  + 3.88  +24.96 
2008 - 3.24  - 1.93  - 0.39  + 0.66  + 0.65  - 5.98  + 2.35  + 2.03  - 2.78  -10.76  - 8.40  + 4.35  -22.03 
2007           + 0.00  - 0.88  + 1.13  + 1.62  + 0.74  - 1.34  - 0.24  + 1.00 
 
Maximum
Sales Charge(%) (1)		 Gross Expense
Ratio (%) (2)		 Net Expense
Ratio (%) (3)
0.00 2.11 2.11
 
(1) Maximum Sales Charge for Class A shares is a percentage of the initial investment and may be reduced based on the size of your investment. Class B and C shares have a contingent deferred sales charge when you redeem your shares depending on your holding period. Please see the Fund's Prospectus or contact your Adviser for a complete description of the applicable sales charge.
(2) Gross Expense Ratio is the expenses of the Fund reflected as a percentage of the Fund's average daily net assets and do not include any voluntary or contractual fee waivers or expense limitations as described in the Fund Prospectus.
(3) Net Expense Ratio is the expenses of the Fund including any voluntary or contractual fee waivers or expense limitations as a percentage of the Fund's average daily net assets. Where applicable, please see the Fund's Prospectus or contact your Adviser for a complete description of the fee waiver or expense limitation, the effective date and the expiration date.

Inception Date: June 28, 2007
The past performance noted does not guarantee future results. Total returns and average annual returns reflect changes in net asset value price, reinvested dividends, rights offerings, spin-offs and capital gains and are net of expenses. Investment results and the principal value of an investment will fluctuate. When shares are sold, they may be worth more or less than their original cost. Due to market volatility, current performance may be higher or lower than the figures shown. Investors should consider the investment objectives, risks, sales charges and expense of the fund carefully before investing. The prospectus contains more complete information about this and other matters. The prospectus should be read carefully before investing.
You can obtain a prospectus by calling Gabelli & Company, Inc. at 1-800-GABELLI (1-800-422-3554), or contacting your financial representative or by visiting http://www.gabelli.com.
Distributed by Gabelli & Company, Inc. One Corporate Center, Rye, NY 10580.